Skip to content
Biophytis
LIVE HEALTHIER LONGER
Biophytis
  • Corporate
    • Executive Committee
    • Scientific Advisory Board
    • Boards of Directors
    • Code of Ethics
  • Our Science
    • BIO101
      • Posters & Publications
        • 2024
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
    • Macuneos (BIO201)
      • Posters & Publications
  • Pipeline
    • Pipeline
    • Key milestones in the development of BIO101
    • Sarcopenia: SARA clinical program
    • Obesity: OBA Clinical Program
    • COVID-19: COVA clinical program
    • Duchenne Muscular Dystrophy: MYODA clinical program
    • Age-related Macular Degeneration: MACA clinical program
  • Investors
    • Letter to shareholders
    • Live Stock Price
    • Corporate Presentation
    • General Meetings
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
    • AMF Regulated Information
    • SEC Filings
    • Financial Calendar
    • Convertible bonds
  • News
    • Press Releases
      • 2025
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
    • Biophytis in Media
  • Recruitment
  • Contact
    • Contact
    • Contact Information
    • Legal information
  • LinkedIn
  • Twitter
  • FR
  • EN
  • Corporate
    • Executive Committee
    • Scientific Advisory Board
    • Boards of Directors
    • Code of Ethics
  • Our Science
    • BIO101
      • Posters & Publications
        • 2024
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
    • Macuneos (BIO201)
      • Posters & Publications
  • Pipeline
    • Pipeline
    • Key milestones in the development of BIO101
    • Sarcopenia: SARA clinical program
    • Obesity: OBA Clinical Program
    • COVID-19: COVA clinical program
    • Duchenne Muscular Dystrophy: MYODA clinical program
    • Age-related Macular Degeneration: MACA clinical program
  • Investors
    • Letter to shareholders
    • Live Stock Price
    • Corporate Presentation
    • General Meetings
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
    • AMF Regulated Information
    • SEC Filings
    • Financial Calendar
    • Convertible bonds
  • News
    • Press Releases
      • 2025
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
    • Biophytis in Media
  • Recruitment
  • Contact
    • Contact
    • Contact Information
    • Legal information
  • LinkedIn
  • Twitter
  • FR
  • EN

Category Archives: Press Releases

June 12, 2019

Press ReleasesBy Antoine12 June 2019

Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon). Read the Press Release

June 07, 2019

Press ReleasesBy Antoine7 June 2019

Biophytis Expands Daniel Schneiderman’s Role to Group Chief Financial Officer. Read the Press Release

May 22, 2019

Press ReleasesBy Antoine22 May 2019

Biophytis announces the publication of its 2018 Reference Document. Read the press release

May 22, 2019

Press ReleasesBy Antoine22 May 2019

Biophytis announces suspension of trading until distribution of a press release. Read the Press Release

May 22, 2019

Press ReleasesBy Antoine22 May 2019

Biophytis announces the resumption of the listing of its stock on May 23, 2019, at the opening of the markets. Read the press release

May 22, 2019

Press ReleasesBy Antoine22 May 2019

Biophytis Files Registration Statement for Proposed Initial Public Offering in the United States. Read the Press Release

May 2, 2019

Press ReleasesBy Antoine2 May 2019

Biophytis Presented A Poster at The Association for Research in Vision and Ophthalmology Annual Meeting. Read the Press Release

April 16, 2019

Press ReleasesBy Antoine16 April 2019

Biophytis announces the release of the 2018 Annual Financial Report and the departure of Jean-Gérard Galvez from the Board of Directors. Read the Press Release

April 04, 2019

Press ReleasesBy Antoine4 April 2019

Biophytis to participate in several investors’ events during the month of April. Read the Press Release

March 27, 2019

Press ReleasesBy Antoine27 March 2019

Biophytis Announces One Oral and Four Poster Presentations at the Myology 2019 Congress. Read the Press Release

←1
23456789101112131415161718192021
…2223242526…
27282930313233
34→
© Biophytis 2006-2025 - Mentions Légales
  • Corporate
    • Executive Committee
    • Scientific Advisory Board
    • Boards of Directors
    • Code of Ethics
Footer Colonne 1 - Anglais
Go to Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.